Regenetech Initiates Preclinical Studies At Johns Hopkins University With Expanded Adult Stem Cells For Type 1 Diabetes Treatment
Nov 18th 2007Drug InformationDiabetes
Regenetech®, Inc. announces that it has signed a Sponsored Research Agreement (SRA) with Johns Hopkins University in order to work toward a treatment for type 1 diabetes. This is in addition to the research agreements which the Company currently has in place with Texas A&M University and the University of Texas Medical Branch at Galveston. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
